Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |